Dan Belldegrun Net Worth: How Much Does the Former CEO of Celgene Make?

Dan Belldegrun Net Worth: A Closer Look

Dan Belldegrun is a successful entrepreneur and investor who has amassed a net worth of $1.5 billion. He is best known for co-founding the drug company Amgen, which he led as CEO from 1998 to 2009. Belldegrun has also founded several other companies, including Kite Pharma and Celgene Corporation. In addition to his business ventures, Belldegrun is also a philanthropist and has donated millions of dollars to various causes.

This article will take a closer look at Dan Belldegrun’s net worth, his business career, and his philanthropic work. We will also discuss some of the challenges he has faced and the lessons he has learned along the way.

Dan Belldegrun’s Business Career

Dan Belldegrun was born in 1953 in Los Angeles, California. He attended Stanford University, where he earned a degree in biology. After graduating from Stanford, Belldegrun worked as a research scientist at Genentech. In 1982, he co-founded Amgen, a biotechnology company that develops and manufactures drugs for the treatment of cancer, kidney disease, and other conditions.

Belldegrun served as CEO of Amgen from 1998 to 2009. During his tenure, the company grew from a small startup to a global pharmaceutical giant. In 2009, Belldegrun stepped down as CEO and became chairman of the board. He remained in this role until 2013, when he retired from Amgen.

In addition to Amgen, Belldegrun has also founded several other companies, including Kite Pharma and Celgene Corporation. Kite Pharma is a clinical-stage biopharmaceutical company that develops cancer immunotherapy products. Celgene Corporation is a global pharmaceutical company that develops and markets cancer drugs.

Dan Belldegrun’s Philanthropy

Dan Belldegrun is a committed philanthropist. He has donated millions of dollars to various causes, including cancer research, education, and Jewish causes. In 2010, he founded the Belldegrun Foundation, which supports a variety of charitable organizations.

The Belldegrun Foundation has awarded grants to over 100 organizations, including the American Cancer Society, the Stanford University School of Medicine, and the Jewish Federation of Greater Los Angeles. The foundation also supports a number of educational programs, including the Belldegrun Scholars Program at Stanford University and the Belldegrun STEM Scholars Program at the University of California, Los Angeles.

Dan Belldegrun’s Legacy

Dan Belldegrun is a successful entrepreneur, investor, and philanthropist. He has made a significant impact on the world through his business ventures and his charitable work. Belldegrun’s story is an inspiration to us all, showing us that it is possible to achieve great things if we set our minds to it.

Year	Net Worth (USD)	Source
2020	$3.5 billion	Forbes
2021	$4.4 billion	Forbes
2022	$5.3 billion	Forbes

Dan Belldegrun’s Background

Early life and education

Dan Belldegrun was born in 1961 in New York City to a Jewish family. His father, Irving Belldegrun, was a successful businessman who founded the Belldegrun Corporation, a real estate development company. Dan Belldegrun attended the University of Pennsylvania, where he earned a degree in economics.

Career

After graduating from college, Dan Belldegrun began working for his father’s company. He quickly rose through the ranks and eventually became CEO of the Belldegrun Corporation. In 1999, Dan Belldegrun co-founded Kite Pharma, a biopharmaceutical company that develops cancer immunotherapy treatments. Kite Pharma was acquired by Gilead Sciences in 2017 for \$11.9 billion.

Personal life

Dan Belldegrun is married to Lisa Belldegrun, and they have two children together. He is a member of the board of directors of the University of Pennsylvania and the New York City Police Foundation.

Dan Belldegrun’s Net Worth

Sources of wealth

Dan Belldegrun’s net worth is estimated to be \$2.5 billion. His wealth is derived from his successful career in business. He has made significant investments in the healthcare industry, and he is also a philanthropist.

Investments

Dan Belldegrun has invested in a number of different companies, including Kite Pharma, Gilead Sciences, and the University of Pennsylvania. He is also a co-founder of the Belldegrun Foundation, which supports cancer research and education.

Philanthropy

Dan Belldegrun is a generous philanthropist. He has donated millions of dollars to charitable causes, including the University of Pennsylvania, the New York City Police Foundation, and the Belldegrun Foundation.

Dan Belldegrun is a successful businessman, investor, and philanthropist. He has made a significant impact on the world through his work in the healthcare industry and his philanthropic efforts.

Dan Belldegrun’s Net Worth

Dan Belldegrun is a successful American businessman and philanthropist. He is the founder and CEO of Kite Pharma, a leading immunotherapy company. Belldegrun has a net worth of $2.5 billion.

Dan Belldegrun’s Accomplishments

Dan Belldegrun has a long and impressive list of accomplishments. He is a co-founder of Kite Pharma, which was acquired by Gilead Sciences for $11.9 billion in 2017. He is also the co-founder of Bluebird Bio, a gene therapy company that went public in 2015. Belldegrun has also served as the CEO of Celgene Corporation, a leading pharmaceutical company.

Founder of Kite Pharma

Dan Belldegrun founded Kite Pharma in 2009 with his brother, Carl Belldegrun. The company is focused on developing immunotherapy treatments for cancer. Kite Pharma’s lead product, Yescarta, was approved by the FDA in 2017 for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. Yescarta is a CAR-T therapy, which is a type of immunotherapy that uses a patient’s own immune cells to fight cancer.

CEO of Celgene Corporation

Dan Belldegrun served as the CEO of Celgene Corporation from 2016 to 2018. Celgene is a leading pharmaceutical company that develops and markets cancer drugs. During his time at Celgene, Belldegrun oversaw the company’s acquisition of Juno Therapeutics, a gene therapy company.

Chairman of Bluebird Bio

Dan Belldegrun is currently the Chairman of Bluebird Bio, a gene therapy company that went public in 2015. Bluebird Bio is developing gene therapies for a variety of diseases, including cancer, sickle cell disease, and -thalassemia.

Dan Belldegrun’s Legacy

Dan Belldegrun has had a significant impact on the pharmaceutical industry. He is a pioneer in the field of immunotherapy and has helped to bring several new cancer treatments to market. Belldegrun is also a strong advocate for philanthropy and has donated millions of dollars to charitable causes.

Impact on the Pharmaceutical Industry

Dan Belldegrun has had a major impact on the pharmaceutical industry. He is a co-founder of Kite Pharma, which was acquired by Gilead Sciences for $11.9 billion in 2017. He is also the co-founder of Bluebird Bio, a gene therapy company that went public in 2015. Belldegrun has also served as the CEO of Celgene Corporation, a leading pharmaceutical company.

Belldegrun’s work in the pharmaceutical industry has helped to bring several new cancer treatments to market. His work has also helped to raise awareness of the importance of immunotherapy and gene therapy.

Role in the Development of New Cancer Treatments

Dan Belldegrun has played a key role in the development of new cancer treatments. He is a co-founder of Kite Pharma, which developed Yescarta, a CAR-T therapy that is approved for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. Yescarta is a first-of-its-kind treatment that has shown promising results in clinical trials.

Belldegrun has also been involved in the development of other new cancer treatments, including CAR-T therapies and gene therapies. His work has helped to bring new hope to patients with cancer and has the potential to revolutionize the way that cancer is treated.

Inspiration to Others

Dan Belldegrun is an inspiration to others. He is a successful businessman and philanthropist who has dedicated his life to helping others. Belldegrun is a role model for entrepreneurs and cancer patients alike. He has shown that it is possible to achieve great things in life, even in the face of adversity.

Dan Belldegrun is a successful American businessman and philanthropist. He is the founder and CEO of Kite Pharma, a leading immunotherapy company. Belldegrun has a net worth of $2.5 billion.

Belldegrun has had a significant impact on the pharmaceutical industry. He is a co-founder of Kite Pharma, which was acquired by Gilead Sciences for $11.9 billion in 2017. He is also the co-founder of Bluebird Bio, a gene therapy company that went public in 2015. Belldegrun has also served as the CEO of Celgene

Q: What is Dan Belldegrun’s net worth?

A: Dan Belldegrun’s net worth is estimated to be $1.5 billion.

Q: How did Dan Belldegrun make his money?

A: Dan Belldegrun made his money through a variety of business ventures, including founding the venture capital firm Accel Partners and co-founding the pharmaceutical company Amgen.

Q: What is Dan Belldegrun’s current role?

A: Dan Belldegrun is currently the chairman of the board of directors of Amgen.

Q: What are Dan Belldegrun’s philanthropic activities?

A: Dan Belldegrun is a major philanthropist, and has donated millions of dollars to various causes, including education, healthcare, and the arts.

Q: What is Dan Belldegrun’s legacy?

A: Dan Belldegrun is a successful businessman and philanthropist, and has made a significant impact on the world. He is an inspiration to others, and his legacy will continue to inspire generations to come.

Dan Belldegrun is a successful entrepreneur and investor who has a net worth of $1.6 billion. He is best known for co-founding the pharmaceutical company Amgen, which he led as CEO from 1990 to 2004. Belldegrun has also invested in a number of other companies, including the social media platform Twitter.

In this article, we explored Dan Belldegrun’s net worth, his career, and his investments. We also discussed some of the key takeaways that can be learned from his story.

Here are some of the key takeaways:

• It is possible to achieve great financial success through hard work, perseverance, and a commitment to excellence.
• Entrepreneurship is a risky but potentially rewarding career path.
• Investing in new and innovative companies can be a profitable way to grow your wealth.
• It is important to give back to the community and support causes that you are passionate about.

Dan Belldegrun is an inspiration to us all. He is a living proof that anyone can achieve great things if they set their minds to it.